In his latest Ekso Bionics stock update, our expert breaks down the company's latest numbers.
- Ekso Bionics Is Taking Incremental Steps Toward Mega Profits
- Ekso Stock Update – New Financing Means New Potential
- Ekso's "Monster" Moment Is Right Around the Corner
- Ekso Stock Update – What Ekso's Latest Move Means for Your Money
- Ekso Bionics: Now the First and Only FDA-Approved Exoskeleton
- Two Important Updates on Ekso Bionics Inc. and Consolidated Water Co.
- Ekso Stock – Better to Be Early Than Bail Because You're Impatient
- Ekso Bionics – 33 Million Strides Taken to Corner a $2.1 Billion Market
- EKSO Stock Price Prediction Shows 1,676% Profit Potential
- The Short Attack on Ekso Bionics (OTC: EKSO) Stock and How to Handle It
- Your Best Investing Questions
- This Little-Known Industry Is Producing the Fastest-Growing Stocks
- EKSO Stock Joins Our 2015 Top Performers
- Score an Extra 655% with EKSO – Make Your Move Now
- Why Ekso Bionics (OTCbb: EKSO) Stock Is a Long-Term Profit Machine
- Make Any Investment Risk "Free" in One Move
On the heels of three major milestones, and with multiple partnerships down the pipeline, Ekso Bionics continues to secure dominance in the exoskeleton market.
Ekso Bionics made a major announcement last week: The company is undertaking a 1-for-7 reverse stock split.
Growth in the human augmentation sector won't happen equally. Whoever redefines this market will capture the lion's share of the $1.8 billion in profits up for grabs.
One of Wall Street's cardinal sins is a "set it and forget it" mentality. What I mean by that is there's often a flurry of interest in specific stocks and then... nothing.
That's too bad because the devil, as they say, is always in the details. In that spirit, let's check in on two of our favorite recommendations today: Ekso Bionics and Consolidated Water.
As you might expect, my email's been flooded with all kinds of questions, comments, and observations since the markets began their 7% slide downward in earnest.
Most are pretty straightforward - oil, the sell-off, China, Social Security, and more - but a number of them deal with our favorite Human Augmentation recommendation, Ekso Bionics.
One, in particular, was exceptionally blunt: Have we backed the wrong horse?
No company captures the imagination the way Ekso Bionics Holdings Inc. (OTCBB: EKSO) does.
The tiny exoskeleton maker just reported earnings and, as you might expect, there's broad-based growth in every metric that matters.
But there's something the media isn't covering.
Ironically, it's the single most important factor in what I believe will ultimately be an exceptionally bright future for the company and savvy investors alike.
Ekso Bionics Holding (OTCBB: EKSO) stock has dipped 41% in the last three months and currently trades near $1.23 per share.
But EKSO stock is a still a long-term buy. In fact, this little-known stock has a profit potential of up to 1,676% in the next five years.
On June 2, Ekso Bionics Holdings Inc. (OTC: EKSO) stock dropped 24. 28% -- thanks to an anonymous individual writing under the name "The Pump Stopper" who launched a vicious attack on the stock.
But if you've been in this game long enough, you know what to look for and why stuff like this isn't a big deal in the grand scheme of things.
Today we're taking a look at four of your most perceptive investing questions. We also answer an inquiry from Stuart Varney.
After all, we know it's far more profitable to learn from each other than it is to go down the road alone. Chances if you're thinking about something, another investor is, too.
Money Morning’s Chief Investment Strategist Keith Fitz-Gerald first told his readers about the incredible profit opportunity in the human augmentation market in October 2014.
Since then, it has provided some of the fastest-growing stocks on the market. And Fitz-Gerald sees the run continuing for years.
“No matter how many times I review the data or I rearrange the puzzle, this is THE trend of the next decade,” Fitz-Gerald said.
It was only a matter of time before Ekso Bionics Holdings Inc. (OTCBB: EKSO) stock broke into the Money Morning "2015 Top Stocks to Invest In" list.
On the year, EKSO stock is up 53.7%. Money Morning Chief Investment Strategist Keith Fitz-Gerald said that EKSO stock is one of his favorite companies right now because it taps into a dynamic market trend.
We've loved EKSO Bionics for some time now. It's revenue has gone up 80% since we first recommended it. Its exports surged 250% in one year.
And Sterne Agee kicked off coverage of the company with a "buy" rating and an initial price target of $1.75 per share.
Ekso Bionics Holdings Inc. (OTCbb: EKSO) stock is one of the best long-term profit plays on the market today.
In fact, our experts say EKSO stock could climb 1,648% from today's opening price within the next five years.
As part of his research process, Fitz-Gerald visited the small Richmond, Calif., company in 2014. The technology he saw was a total game-changer.